|
Diabetes Medication Article
Background Information about Insulin
When we eat, our bodies break food down into organic compounds, one of
which is glucose.
The cells of our bodies use glucose as a source of energy for movement,
growth, repair, and other functions. But before the cells can use glucose,
it must move from the bloodstream into the individual cells. This process
requires insulin.
Insulin is produced by the beta cells in the islets of Langerhans in the pancreas. When glucose enters our blood, the pancreas should automatically produce the right amount of insulin to move glucose into our cells. People with type 1 diabetes produce no insulin. People with type 2 diabetes do not always produce enough insulin.
Diabetes Testing Center
Heart News Center
Hot Home Gym Reviews
The Secret Wisdom You Have Inside
Get Rid of Your Belly fat
New Diabetic Drug News
New Diabetic Drug
IMPORTANT: Bing News RSS feed has moved!
Amylin executives say the new drug's convenient regimen will give it a competitive advantage in the marketplace. However, after multiple delays it enters a crowded market, including one diabetes treatement in the same class that has shown superior results.
Read moreAmylin's long-delayed diabetes drug gets FDA nod
It has been recently revealed in a report that the new proposal of Amylin Pharmaceutical company for a more convenient and novel type of diabetes drug has been approved by the Food and Drug Administration. This shall now give way for a new type of Type 2 ...
Read moreNew Diabetes Drug Approved for Once a Week Dosage
Diabetes in a New Light, which offers tips on food preparation, stress management and working with doctors on treatment. She has contributed diabetes-friendly recipes to the website and takes the company's drug Victoza, a once-daily noninsulin ...
Read moreTV chef Paula Deen touts diabetes drug along with high-fat Southern cooking
The Food and Drug Administration has decided not to approve the first of a new class of diabetes drugs, saying that more information was needed to assess the medicine’s safety and effectiveness. The agency’s decision was announced Thursday ...
Read moreF.D.A. Delays Approval of New Diabetes Drug
Novo Nordisk ($NVO) is setting up a new R&D center in Seattle that aims at reengineering the model for early-stage drug work and speeding up development in the diabetes field. Under the direction of noted investigator Matthias von Herrath (see ...
Read moreNovo crafts fast-track R&D model for new diabetes drug unit
In 2005, news broke that researchers in Scotland found low rates of cancer among diabetics taking metformin, a drug commonly prescribed to patients with Type 2 diabetes. Many follow-up studies reported similar findings, some suggesting as much ...
Read moreDiabetes Drug May Reduce Cancer Risk
which provides glycemic control for diabetes type 2 in a once-weekly injection. The approval follows two earlier rejections in 2010, when the FDA asked the company to go back and carry out a new trial of the drug's effect on heart rhythm.
Read moreAmylin's Once-Weekly Diabetes Injection Finally Wins FDA Approval
TRENTON, New Jersey — An experimental Type 2 diabetes drug Bristol-Myers Squibb Co. and AstraZeneca PLC are jointly developing has been held up by U.S. regulators, months after expert advisers to the government raised concerns about cancer ...
Read moreUS won't approve Bristol-Astra diabetes drug yet
will still tether legions of diabetics to its drug. Case in point is Novo Nordisk and Paula Deen's inaugural recipe for its "Diabetes in a New Light" campaign -- a semi-reduced-fat seven-cheese beef lasagna.
Read more